Journals / Türk Kardiyoloji Derneği Arşivi / 2021 / Cilt: 49 - Sayı: 7

Relationship between disease severity and atrial fibrillation in chronic obstructive pulmonary disease

Kronik obstrüktif akciğer hastalığında hastalık şiddeti ile atriyal fibrilasyon arasındaki ilişki

Pages
517–521
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Regardless of the forced expiratory volume – first second (FEV1 ) value in the respiratory test, the incidence of AF is higher in patients with COPD with a clinically more severe picture.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study was to elucidate the relationship between atrial fibrillation (AF) and chronic obstructive pulmonary disease (COPD) classification based on clinical severity determined in current guidelines.
📊
Key Findings & Data:Methods: Patients who received inpatient treatment for COPD between November 2019 and January 2017 were screened.
💡
Conclusion & Impact:Conclusion: Regardless of the forced expiratory volume – first second (FEV1 ) value in the respiratory test, the incidence of AF is higher in patients with COPD with a clinically more severe picture.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of this study was to elucidate the relationship between atrial fibrillation (AF) and chronic obstructive pulmonary disease (COPD) classification based on clinical severity determined in current guidelines. AF is the most common chronic arrhythmia that requires treatment. COPD is one of the risk factors for AF, but this relationship was only explored through respiratory function test results. Methods: Patients who received inpatient treatment for COPD between November 2019 and January 2017 were screened. Patients with coronary artery disease, heart failure, valvular heart disease, diabetes, chronic kidney disease, hypertension, thyroid dysfunction, and sleep apnea syndrome were excluded. According to the 2019 Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines, patients with COPD were divided into groups A, B, C, and D, and the relationship between AF and these groups was investigated. Results: There was no difference between the two groups (depending on the presence of AF) in terms of sex and body mass index. There was a significant difference between the two groups in terms of age, left ventricular ejection fraction (LVEF), left atrium, right atrium, right ventricle, and systolic pulmonary artery pressure. When patients with COPD were classified according to clinical and symptomatic severity, the frequency of AF increased as the clinical severity increased. Conclusion: Regardless of the forced expiratory volume – first second (FEV1 ) value in the respiratory test, the incidence of AF is higher in patients with COPD with a clinically more severe picture.

Özet

Amaç: Atriyal fibrilasyon (AF), en sık görülen tedavi gerektiren kronik aritmidir. Kronik obstruktif akciğer hastalığı (KOAH), AF için risk faktörlerinden biridir, ancak bu ilişki sadece solunumu fonksiyon testi sonuçları üzerinden irdelenmiştir. Çalışmadaki amacımız güncel kılavuzlarda belirlenen klinik ciddiyete bağlı KOAH sınıflaması ile AF arasındaki ilişkinin aydınlatılmasıdır. Yöntemler: Kasım 2019 ve Ocak 2017 arasında KOAH nedeni ile yatarak tedavi alan hastalar tarandı. Koroner arter hastalığı, kalp yetersizliği, kalp kapak hastalığı, diyabet, kronik böbrek hastalığı, hipertansiyon, tiroid disfonksiyonu ve uyku apne sendromu olan hastalar dışlandı. 2019 Global Initiative for Chronic Obstructive Lung Disease (GOLD) kılavuzuna göre KOAH hastaları A,B,C ve D gruplarına ayrıldı ve bu gruplar ile AF ilişkisi araştırıldı. Bulgular: Cinsiyet ve beden kitle indeksi açısından iki grup arasında fark yoktu. Yaş, LVEF, sol atrium, sağ atrium, sağ ventrikül ve SPAB açısında her iki grup arasında anlamlı fark mevcuttu. Klinik ve semptomatik ciddiyete göre KOAH hastaları sınıflandırıldığında, klinik ciddiyet arttıkça AF sıklığı artmaktaydı. Sonuç: Solunum testindeki FEV1değerinden bağımsız olarak, klinik olarak daha ciddi tabloya sahip KOAH olgularında AF görülme sıklığı daha fazladır.

🔖

Cite This Article

Bulut, S., Şahan, E. (2022). Relationship between disease severity and atrial fibrillation in chronic obstructive pulmonary disease. Türk Kardiyoloji Derneği Arşivi, Cilt: 49 - Sayı: 7, 517–521. https://ajindex.com/articles/631905

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation 2014;129:837-47. [Crossref] 2. Staerk L, Sherer JA, Ko D, Benjamin EJ, Helm RH. Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes. Circ Res 2017;120:1501-17. [Crossref] 3. Guo Y, Tian Y, Wang H, Si Q, Wang Y, Lip GYH. Prevalence, incidence, and lifetime risk of atrial fibrillation in China: new insights into the global burden of atrial fibrillation. Chest 2015; 147(1): 109-19. doi: 10.1378/chest.14-0321. [Crossref] 4. Buch P, Friberg J, Scharling H, Lange P, Prescott E. Reduced lung function and risk of atrial fibrillation in the Copenhagen City Heart Study. Eur Respir J 2003;21:1012-6. [Crossref] 5. Singh D, Agusti A, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019. Eur Respir J 2019;53:1900164. [Crossref] 6. Durheim MT, Holmes DN, Blanco RG, Allen LA, Chan PS, Freeman JV, et al. Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation. Heart 2018;104:1850-8. [Crossref] 7. Agusti AG, Barbera JA, Roca J, Wagner PD, Guitart R, Rodriguez-Roisin R. Hypoxic pulmonary vasoconstriction and gas exchange during exercise in chronic obstructive pulmonary disease. Chest 1990;97:268-75. [Crossref] 8. Huang CX, Liu Y, Xia WF, Tang YH, Huang H. Oxidative stress: a possible pathogenesis of atrial fibrillation. Med Hypotheses 2009;72:466-7. [Crossref] 9. Wilchesky M, Ernst P, Brophy JM, Platt RW, Suissa S. Bronchodilator use and the risk of arrhythmia in COPD: part 2: reassessment in the larger Quebec cohort. Chest 2012;142:305-11. [Crossref] 10. Singh S, Loke YK, Enright P, Furberg CD. Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications. Thorax 2013;68:114-6. [Crossref] 11. Arcasoy SM, Christie JD, Ferrari VA, Sutton MS, Zisman DA, Blumenthal NP, et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 2003;167:735-40. [Crossref]